The need for green and sustainable chemistry for use in the pharmaceutical and other chemical industries is increasingly critical as we face the environmental challenges of the twenty-first century. Unfortunately, available funding to support research for the kind of innovative and sustainable solutions required has not kept pace with this need. Adding to this, it is often very difficult to receive funding for ideas without preliminary results, while obtaining preliminary results will indeed require funding. The ACS GCI Pharmaceutical Roundtable (ACS GCIPR) is seeking to provide ‘ignition’ funding for novel and innovative ideas that have the potential to provide sustainable solutions to chemistry and engineering problems relevant to the pharmaceutical industry from discovery to manufacturing. The goal is to provide researchers with initial funding to obtain preliminary results that may then be used by the researchers to help apply for funding from traditional funding agencies. The ACS GCI Pharmaceutical Roundtable will provide $25,000 in ‘ignition’ funding for up to four proposals. Proposals on any chemistry or engineering topics relevant to green and sustainable discovery and manufacture of pharmaceutical products will be considered; however, a list of key green chemistry and engineering research areas has been previously published by the ACS GCIPR and represents areas of particular interest.
Proposals must be limited to three pages, one of which is a title page. The proposal should focus on the objectives, specific aims, investigations planned and brief discussion of why the proposed chemistry will be more sustainable than the current state of the art. A very brief description of the budget and timelines should also be included. The following sections should not be included in the proposal: abstract, background, references, current funding, facilities description, collaborations/IP considerations. Once a proposal is selected to receive funding, more details on some of the above items may be requested. The proposed research must not be currently funded by any private or public grants.